// App-Quantinova.ai

3054 : CD47 signaling regulates a DNA damage response pathway by suppressing the expression of Schlafen-11 (SLFN11)

Researchers

Presenter

  • Anthony L. Schwartz

Principal Investigators

  • Sukhbir Kaur

  • Sai-Wen Tang

  • Yves Pommier

  • David D. Roberts

Medical Centers

  • National Institute of Health, Bethesda, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Thrombospondin-1

Drug/Treatment

  • thrombospondin-1

  • Cisplatin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A